UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 3, 2020

 

  BiomX Inc.  
  (Exact Name of Registrant as Specified in its Charter)  

 

Delaware   0001-38762   82-3364020
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

7 Pinhas Sapir St., Floor 2
Ness Ziona, Israel 		  7414002
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (972) 72-394-2377

 

  n/a  
  (Former name or former address, if changed since last report)  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half share of Common Stock   PHGE.U   NYSE American
Shares of Common Stock, $0.0001 par value, included as part of the Units   PHGE   NYSE American
Warrants included as part of the Units   PHGE.WS   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 3, 2020, BiomX Inc. (the “Company”) held its 2020 Annual Meeting of Stockholders. At the meeting, stockholders voted in favor of all items of business, as indicated below:

 

Proposal No. 1—Election of Directors

 

The Company’s stockholders voted to elect the following persons to the board of directors of the Company as Class I, II and III directors to serve until the 2021, 2022 and 2023 Annual Meetings of Stockholders, respectively:

 

Nominee   Class   Votes For     % Votes For     Votes Withheld     %Votes Withheld     Broker Non-Votes  
Yaron Breski   I     9,749,813       99.94       5,399       0.06       857,327  
Erez Chimovits   I     9,752,813       99.98       2,399       0.02       857,327  
Dr. Gbola Amusa   II     9,752,638       99.97       2,574       0.03       857,327  
Jonas Grossman   II     9,752,713       99.97       2,499       0.03       857,327  
Dr. Russell Greig   III     9,752,813       99.98       2,399       0.02       857,327  
Jonathan Solomon   III     9,752,813       99.98       2,399       0.02       857,327  
Lynne Sullivan   III     9,752,738       99.97       2,474       0.03       857,327  

 

Proposal No. 2—Ratification of Selection of Independent Registered Public Accounting Firm For Fiscal 2020

 

The Company’s stockholders voted to ratify the selection of Brightman Almagor Zohar & Co. as the independent registered public accounting firm for the fiscal year ending December 31, 2020.

 

Votes For     % Votes For     Vote Against     % Votes Against     Abstain     Broker Non-Votes  
  10,611,073       100.00       0       0.00       1,466       0  

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOMX INC.
     
June 8, 2020 By: /s/ Jonathan Solomon
    Name:  Jonathan Solomon
    Title:  Chief Executive Officer

 

 

2

 

BiomX (AMEX:PHGE.U)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more BiomX Charts.
BiomX (AMEX:PHGE.U)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more BiomX Charts.